Core Insights - The increasing prevalence of myopia among Chinese youth has led to a rise in the use of orthokeratology lenses (OK lenses), which in turn drives the demand for lens care solutions [1][10] - The market for orthokeratology lens care solutions is projected to reach a consumption population of 2.7943 million by 2024, with a year-on-year growth of 10.46% [1][10] - The total demand for orthokeratology lens care solutions in China is expected to reach 52.6437 million liters, with a market size of 5.758 billion yuan in 2024 [1][11] Industry Overview - Orthokeratology lenses are classified as Class III medical devices by the National Medical Products Administration of China, designed to temporarily reshape the cornea and are effective in controlling myopia progression [2][4] - The care solutions for these lenses are essential for cleaning, disinfecting, and maintaining a safe storage environment, ensuring user comfort and safety [2][3] Market Demand and Supply - The demand for orthokeratology lens care solutions is segmented into three categories: lubricating solutions (38.43%), care solutions (24.89%), and cleaning solutions (36.68%) [1][11] - The largest sales channel for these care solutions is hospitals, accounting for 69.5% of sales, with public hospitals at 35.5% and private hospitals at 34.0% [7] Development Background - The industry has evolved significantly since 1992, when Bausch & Lomb established a production line in Shanghai, marking the beginning of the domestic lens care solution market [4][5] - The introduction of domestic brands in 2003, such as Haichang, has increased competition and reduced reliance on imported products [4] Competitive Landscape - The market has traditionally been dominated by foreign brands like Bausch & Lomb and Mylacon, but domestic brands such as Oupai Kangshi and Aibonuode are gaining market share due to competitive pricing and distribution strategies [11][12] - Oupai Kangshi reported a revenue of 871 million yuan in the first half of 2025, with care products contributing 12.58% of total revenue [13] - Aibonuode achieved a revenue of 787 million yuan in the same period, with a gross profit margin of 65.25% [13] Future Trends - The future of orthokeratology lens care solutions will likely include enhanced formulations with beneficial ingredients like Vitamin B and sodium hyaluronate to improve comfort and moisture retention [14] - Customization of products for specific user needs, such as preservative-free solutions for sensitive eyes, is expected to become more prevalent [14]